Der Gynäkologe

, Volume 42, Issue 6, pp 402–408 | Cite as

Intraoperative Strahlentherapie beim Mammakarzinom

  • D. Bottke
  • R. Dourdoumas
  • T. Wiegel
  • R. Kreienberg
  • G. Sauer
Leitthema
First Online:
  • 59 Downloads

Zusammenfassung

Standard der postoperativen Strahlentherapie des brusterhaltend operierten Mammakarzinoms ist die homogene Bestrahlung der gesamten Brust bis zu einer Gesamtdosis von 50 Gy mit einer anschließenden Aufsättigung des Tumorbettes (Boost). Aus der vermehrten Feststellung von kleinen Mammakarzinomen bei postmenopausalen Patientinnen durch das Mammographiescreening ergibt sich die Notwendigkeit, über mögliche Veränderungen der bisherigen Therapiegewohnheiten nachzudenken. Nachdem der Großteil der Lokalrezidive im Bereich der ehemaligen Tumorhöhle auftritt, wird diskutiert, ob die alleinige Bestrahlung des Tumorbettes die Behandlung der gesamten Restbrust ersetzen kann. Publizierte Ergebnisse von Teilbrustbestrahlungen (sowohl intra- als auch postoperativ) zeigen ein sehr hohes Maß an lokaler Kontrolle bei Nachbeobachtungszeiten von bis zu 11 Jahren. Prospektive und randomisierte Studien untersuchen derzeit, bei welchen Patientinnen eine intraoperative Strahlentherapie (IORT) als alleinige Methode der Strahlenbehandlung nach vorausgegangener Operation ausreichend ist. Gemäß einer aktuellen Stellungnahme der Deutschen Gesellschaft für Radioonkologie (DEGRO) ist die IORT als Boost mit nachfolgender perkutaner Ganzbrustbestrahlung schon jetzt möglich.

Schlüsselwörter

Intraoperative Strahlentherapie Brusterhaltende Therapie Mammakarzinom 

Intraoperative radiotherapy for breast cancer

Abstract

The standard postoperative radiotherapy after breast-conserving surgery is percutaneous irradiation of the entire breast to a total dose of 50 Gy, usually followed by a tumor bed boost. Due to the increased detection of small breast carcinomas by mammographic screening, it is necessary to consider a possible change of the existing therapeutic practice. Since the majority of local recurrences are close to the former tumor bed, the question arises whether tumor bed irradiation alone might be a therapeutic alternative to total breast irradiation. Published results of partial irradiation of the breast (intra- as well as postoperatively) show a very high degree of local control with follow-ups up to 11 years. Ongoing prospective and randomized studies are investigating which patients are suited to intraoperative radiotherapy as the sole irradiation method following surgery. According to a relevant statement of the DEGRO, intraoperative radiotherapy as a boost preceding percutaneous whole-breast irradiation is already possible.

Keywords

Intraoperative radiotherapy Breast-conserving therapy Breast cancer 
This is a preview of subscription content, log in to check access.

Notes

Interessenkonflikt

Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.

Literatur

  1. 1.
    Bartelink H, Horiot JC, Poortmans P et al (2001) Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. N Engl J Med 345:1378–1387PubMedCrossRefGoogle Scholar
  2. 2.
    Bartelink H, Horiot JC, Poortmans PM et al (2007) Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial. J Clin Oncol 25:3259–3265PubMedCrossRefGoogle Scholar
  3. 3.
    Clarke M, Collins R, Darby S et al (2005) Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: An overview of the randomized trials. Lancet 366:2087–2106PubMedGoogle Scholar
  4. 4.
    Collette S, Collette L, Budiharto T et al (2008) Predictors of the risk of fibrosis at 10 years after breast converving therapy for early breast cancer: A study based on the EORTC Trial 22881-10882 boost versus no boost. Eur J Cancer 44:2587–2599PubMedCrossRefGoogle Scholar
  5. 5.
    Fisher B, Anderson S (1994) Conservative surgery for the management of invasive and noninvasive carcinoma of the breast: NSABP trials. National Surgical Adjuvant Breast and Bowel Project. World J Surg 18:63–69PubMedCrossRefGoogle Scholar
  6. 6.
    Fisher B, Anderson S, Bryant J et al (2002) Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 347:1233–1241PubMedCrossRefGoogle Scholar
  7. 7.
    Fortuna G, Ciccone V, Palloni et al (2001) Randomised study on IORT for T1-T2 breast cancer. Proceedings from the International Congress of Radiation Oncologists (ICRO), Melborne, Australia. AbstractGoogle Scholar
  8. 8.
    Herskind C, Schalla S, Hehn EW et al (2006) Influence of different dose rates on cell recovery and RBE at different spatial positions during protracted conformal radiotherapy. Radiat Prot Dosim 122:498–505CrossRefGoogle Scholar
  9. 9.
    Intra M, Leonardi C, Luini A et al (2005) Full-dose intraoperative radiotherapy with electrons in breast surgery: Broadening the indications. Arch Surg 140:936–939PubMedCrossRefGoogle Scholar
  10. 10.
    King TA, Bolton JS, Kuske RR et al (2000) Long-term results of wide-field brachytherapy as the sole method of radiation therapy after segmental mastectomy for T(is,1,2) breast cancer. Am J Surg 180:299–304PubMedCrossRefGoogle Scholar
  11. 11.
    Lilla C, Ambrosone CB, Kropp S et al (2007) Predictive factors for late normal tissue complications following radiotherapy for breast cancer. Breast Cancer Res Treat 106:143–150PubMedCrossRefGoogle Scholar
  12. 12.
    Liljegren G, Holmberg L, Bergh J et al (1999) 10-Year results after sector resection with or without postoperative radiotherapy for stage I breast cancer: A randomized trial. J Clin Oncol 17:2326–2333PubMedGoogle Scholar
  13. 13.
    Luini A, Orecchia R, Gatti G et al (2005) The pilot trial on intraoperative radiotherapy with electrons (ELIOT): Update on the results. Breast Cancer Res Treat 93:55–59PubMedCrossRefGoogle Scholar
  14. 14.
    Merrick HW, Hager E, Dobelbower RR (2003) Intraoperative radiation therapy for breast cancer. In: Merrick HW, Thomas CR (Hrsg) Intraoperative radiotherapy. Surg Oncol Clin N Am 12:S 1065–1078Google Scholar
  15. 15.
    Orecchia R, Ciocca M, Lazzari R et al (2003) Intraoperative radiation therapy with electrons (ELIOT) in early-stage breast cancer. Breast 12:483–490PubMedCrossRefGoogle Scholar
  16. 16.
    Reitsamer R, Peintinger F, Kopp M et al (2004) Local recurrence rates in breast cancer patients treated with intraoperative electron-boost radiotherapy versus postoperative external-beam electron-boost irradiation. Strahlenther Onkol 180:38–44PubMedCrossRefGoogle Scholar
  17. 17.
    Sautter-Bihl ML, Budach W, Dunst J et al (2007) DEGRO Practical Guidelines for radiotherapy of breast cancer I. Breast-conserving therapy. Strahlenther Onkol 183:661–666PubMedCrossRefGoogle Scholar
  18. 18.
    Kreienberg R, Kopp I, Albert U et al (2008) Interdisziplinäre S3-Leitlinie für die Diagnostik, Therapie und Nachsorge des Mammakarzinoms, 1. Aktualisierung, Zuckschwerdt, MünchenGoogle Scholar
  19. 19.
    Vaidya JS, Baum M, Tobias JS et al (2001) Targeted intra-operative radiotherapy (Targit): An innovative method of treatment for early breast cancer. Ann Oncol 12:1075–1080PubMedCrossRefGoogle Scholar
  20. 20.
    Vaidya JS, Baum M, Tobias JS et al (2002) The novel technique of delivering targeted intraoperative radiotherapy (Targit) for early breast cancer. Eur J Surg Oncol 28:447–454PubMedCrossRefGoogle Scholar
  21. 21.
    Veronesi U, Cascinelli N, Mariani L et al (2002) Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 347:1227–1232PubMedCrossRefGoogle Scholar
  22. 22.
    Veronesi U, Gatti G, Luini A et al (2003) Intraoperative radiation therapy for breast cancer: technical notes. Breast J 9:106–112PubMedCrossRefGoogle Scholar
  23. 23.
    Veronesi U, Orecchia R, Luini A et al (2008) Full dose intraoperative radiotherapy with electrons (ELIOT) during breast conserving surgery – experience with 1246 cases. ecancermedicalscience 1:65Google Scholar

Copyright information

© Springer Medizin Verlag 2009

Authors and Affiliations

  • D. Bottke
    • 1
  • R. Dourdoumas
    • 1
  • T. Wiegel
    • 1
  • R. Kreienberg
    • 2
  • G. Sauer
    • 2
  1. 1.Klinik für Strahlentherapie und RadioonkologieUniversitätsklinikum UlmUlmDeutschland
  2. 2.Universitätsfrauenklinik UlmUlmDeutschland

Personalised recommendations